CytoSorbents Corporation (CTSO)

[techxen]

I don't want to stir up something here, and maybe this is just me, but the past couple of months I have seen Dr. Claudio Ronco (a key opinion leader for Cytosorb) authoring papers and publishing information on HA380.

For those of you that are not aware, HA380 is a hemoperfusion filter similar to Cytosorb that is manufactured by Chinese firm Jafron and sold in China.

http://www.jafron.com/index.php?m=content&c=index&a=show&catid=103&id=2800

Jafron's CA330 is supposed to be their improved version that targets more mid-molecular weight toxins and cytokines but I believe it is still in clinical studies. I posted some information about it here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147235160

Dr. Ronco has been one of the key opinion leaders for Cytosorb for many years, but since the coronavirus has come on the scene he has co-authored an upcoming paper on the use of HA330 and publish some YouTube videos.

Now today, I just found a new clinical trial posted just yesterday for an observational study for sepsis using HA380:
https://www.clinicaltrials.gov/ct2/show/NCT04306419-Observational Trial on Cytokine Adsorption in Sepsis (OuTCASt), which get this - is being run out of one of the same hospitals in Germany that has done studies on Cytosorb.

Now I know doctors like to look at different therapies for different applications but what gives here? Has Dr. Ronco gone to the 'dark side'? What are China filters doing in Germany and what are German filters (Cytosorb) doing in China?

Man the world has gone mad...or maybe I am just losing it.